Nicole LaBrosse - 20 Feb 2026 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF FINANCIAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
20 Feb 2026
Net transactions value
-$459,008
Form type
4
Filing time
24 Feb 2026, 18:14:46 UTC
Previous filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO /s/ James R. Oehler, Attorney-in-Fact 24 Feb 2026 0001910662

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +5,332 +16% $0.000000 38,290 20 Feb 2026 Direct
transaction HALO Common Stock Tax liability $204,138 -2,876 -7.5% $70.98 35,414 20 Feb 2026 Direct F1
transaction HALO Common Stock Options Exercise $0 +6,688 +19% $0.000000 42,102 23 Feb 2026 Direct
transaction HALO Common Stock Tax liability $254,869 -3,608 -8.6% $70.64 38,494 23 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -5,332 -25% $0.000000 15,995 20 Feb 2026 Common Stock 5,332 $0.000000 Direct F3
transaction HALO Performance Stock Units Options Exercise $0 -6,688 -16% $0.000000 36,357 23 Feb 2026 Common Stock 6,688 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 2,876 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 The reported disposition of 3,608 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.